Digraph

2020-01 Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
Dual therapy for 7 days effectively eradicates H. Pylori, finds studyhttps://medicaldialogues.in/gastroenterology/news/dual-therapy-for-7-days-effectively-eradicates-h-pylori-finds-study-62635
2020-01 Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan | Guthttps://gut.bmj.com/content/early/2020/01/08/gutjnl-2019-319954
2020-01 Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Showing topic

2020-01 Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
Antibiotic-resistant Helicobacter pylori